- Home
- IZEA vs BOLD Comparison
IZEA vs BOLD Comparison
Compare IZEA & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZEA
- BOLD
- Stock Information
- Founded
- IZEA 2006
- BOLD 2018
- Country
- IZEA United States
- BOLD United States
- Employees
- IZEA N/A
- BOLD N/A
- Industry
- IZEA Advertising
- BOLD
- Sector
- IZEA Consumer Discretionary
- BOLD
- Exchange
- IZEA Nasdaq
- BOLD Nasdaq
- Market Cap
- IZEA 29.1M
- BOLD 30.3M
- IPO Year
- IZEA N/A
- BOLD 2024
- Fundamental
- Price
- IZEA $2.71
- BOLD $1.05
- Analyst Decision
- IZEA
- BOLD Buy
- Analyst Count
- IZEA 0
- BOLD 3
- Target Price
- IZEA N/A
- BOLD $4.00
- AVG Volume (30 Days)
- IZEA 50.1K
- BOLD 205.8K
- Earning Date
- IZEA 08-13-2025
- BOLD 08-11-2025
- Dividend Yield
- IZEA N/A
- BOLD N/A
- EPS Growth
- IZEA N/A
- BOLD N/A
- EPS
- IZEA N/A
- BOLD N/A
- Revenue
- IZEA $36,896,490.00
- BOLD N/A
- Revenue This Year
- IZEA $22.24
- BOLD N/A
- Revenue Next Year
- IZEA N/A
- BOLD N/A
- P/E Ratio
- IZEA N/A
- BOLD N/A
- Revenue Growth
- IZEA 7.17
- BOLD N/A
- 52 Week Low
- IZEA $1.68
- BOLD $1.01
- 52 Week High
- IZEA $3.15
- BOLD $6.24
- Technical
- Relative Strength Index (RSI)
- IZEA 54.63
- BOLD N/A
- Support Level
- IZEA $2.51
- BOLD N/A
- Resistance Level
- IZEA $2.84
- BOLD N/A
- Average True Range (ATR)
- IZEA 0.11
- BOLD 0.00
- MACD
- IZEA -0.05
- BOLD 0.00
- Stochastic Oscillator
- IZEA 57.29
- BOLD 0.00
About IZEA IZEA Worldwide Inc.
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.